Salute e Benessere

Fairland COP7 R290 ATW HeatPump - The Future of AI HeatPump

First COP 7.0 AI Heat Pump FirstCOP 7.0AI Heat Pump The Fairland R290 ATW Heat Pump is the first on the market to achieve aCOP of 7.0, a breakthrough enabled by innovative structural design andFairland's AI Inverter technology. With dual A+++ level performance, it redefines energy efficiency, delivering around 40% higher efficiency than average systems. Its preciseAI control optimizesR290 refrigerant use, ensuring safe, efficient operation and every component works in...
PR Newswire
27/10/2025

Amphista Therapeutics’ successful degradation of a key cancer target, BRD9, via…

The publication reports the highly selective, DCAF16 E3 enabled degradation of BRD9in vivousing Amphista’s proprietary, next generation Targeted Glue™ medicinal chemistry technologyAmphista’s scientists prospectively and rationally designed therapeutic molecules with a novel mechanism, intrinsic oral bioavailability and favourable drug-like propertiesAmphista’s proprietary Targeted Glues™ offer an exciting new strategy for targeted protein degradation in acute myeloid leukaemia and...
Nasdaq GlobeNewswire
27/10/2025

NHS-licensed healthcare platform Evaro partners with period tracking app Clue in…

Partnership bridges the gap between period tracking and contraception access as nearly half of UK women face barriers to contraception care Clue , the #1 women-led period and cycle tracker trusted by over 100 million worldwide, to provide seamless access to NHS-funded contraception directly through Clue's app.This marks the first time a major cycle-tracking platform has integrated prescription healthcare services in the UK, creating a critical solution as the country grapples with an...
Nasdaq GlobeNewswire
27/10/2025

Implantica presents the third quarter 2025 on October 31 at 15:00 CET

If you wish to participate via webcast, please use the following link: If you wish to participate via webcast, please use the following link: If you wish to participate via teleconference, please register on the link below. After registration, you will be provided the phone number and a conference ID to access the conference. Speakers: For further information, please contact: Nicole Pehrsson, Investor Relations Telephone (CH): +41 43 505 20 [email protected] ...
PR Newswire
27/10/2025

Inside information: Bioretec is revising its financial targets, deems that the…

The Company is currently in the process of assessing and updating its overall commercialization strategy and pipeline and will be providing an update by the end of 2025. However, in the course of its assessment, the Board of Directors of Bioretec has now concluded that the financial targets published on 4 October 2024 are unattainable and will likely not be met. In particular, the Board of Directors of Bioretec deems that the target of reaching net sales of EUR 65 million by the end of the year…
PR Newswire
27/10/2025

Stockholm hospitals unify all imaging in Sectra's cloud service to boost…

"By consolidating all imaging into a unified system across all hospitals and specialties, our staff can efficiently access and share images regardless of location. This enables streamlined region-wide workflows, supporting the management of referrals, examinations, and diagnoses—ultimately contributing to improved patient safety," says Mikael Ohrling, Director of Healthcare, Region Stockholm. "By consolidating all imaging into a unified system across all hospitals and specialties…
PR Newswire
27/10/2025

Cipla's flagship respiratory initiative Breathefree broadens its footprint in…

Cipla is launching the first phase of Breathefree UAE with a localized, bilingual website and educational videos to guide patients on the correct use of its respiratory devices. The platform will provide tailored resources, device training, and a scalable ecosystem that will gradually expand to include adherence tools such as reminder alerts and digital educators. Cipla is launching the first phase of Breathefree UAE with a localized, bilingual website and educational videos to guide patients...
PR Newswire
27/10/2025

Klea Holding strengthens its presence in Dubai with its first strategic real…

Paris, 27 October 2025 KLEA HOLDING (FR0013481835 – ALKLH), a group specialising in the acquisition, development and digitalisation of companies in various sectors, announces its first real estate investment in Dubai as part of a prestigious office property development project, Lumena Alta, developed by Omniyat, one of the emirate's most reputable developers…
Actusnews Wire
27/10/2025

World's First Multi-Omics LLM, Promising to Decode the Language of Human Biology…

PanOmiQ’s foundational model trained on multi-Omics data breakthrough FPGA-powered deployment addresses data sovereignty challenge, ultrafast AI-driven multi-omics analysis on premises, redefining speed and accuracy in precision medicine ‘The BioIntelligence™’powers its flagship platform, PanOmiQ™, which will be showcased at the Global Health Exhibition – Riyadh, offering a new paradigm where biology is not just measured, but truly understood.The central failure of modern medicine is...
Nasdaq GlobeNewswire
27/10/2025

Health Canada Grants Authorization for Leqembi® (lecanemab)

The approval of Leqembi is based on the large global Phase 3 Clarity AD study. In the Clarity AD study, Leqembi met its primary endpoint and all key secondary endpoints with statistically significant results.2,3 Leqembi has been issued market authorization in Canada with conditions, pending the results of trials to verify its clinical benefit. Eisai plans to submit clinical assessment data captured from participants in real-world clinical practice. The approval of Leqembi is based on the…
PR Newswire
27/10/2025

138th Canton Fair Showcases Practical Aesthetics in Home and Garden Innovation

Another exhibitor is turning agricultural by-products into valuable decorative items. Through circular design principles, discarded materials such as tea and mulberry branches are repurposed into high-end crafts, achieving full reuse of raw materials and significantly reducing agricultural waste. Among its featured products, the Tea Branch Art Frame Series and Color Wood Inlay Ornaments have attracted attention for their fusion of natural textures, Chinese design motifs, and Western decorative…
PR Newswire
27/10/2025

New Global Coalition Launches to Address the Hidden Threat of RSV in Adults

With core members including leading advocacy organizations the International Federation on Ageing (IFA) and the Global Allergy and Airways Patient Platform (GAAPP), alongside GSK, and with the European Scientific Working Group on Influenza (ESWI) providing scientific oversight, the RSV Alliance seeks to drive education, advocacy, and collaboration to improve prevention and care for those most vulnerable to RSV.RSV is often thought to primarily affect infants and young children, but it also...
Nasdaq GlobeNewswire
26/10/2025

Novartis agrees to acquire Avidity Biosciences, an innovator in RNA…

Ad hoc announcement pursuant to Art. 53 LR Transaction strengthens neuroscience franchise for Novartis with three late-stage programs that address genetic neuromuscular diseasesAdvances the Novartis xRNA strategy by adding a scientifically robust, muscle-directed, Antibody Oligonucleotide Conjugates (AOCs™) platform and first-in-disease pipelineExpected to unlock multi-billion-dollar opportunities with planned product launches before 2030 Raises expected 2024-2029 sales CAGR...
Nasdaq GlobeNewswire
26/10/2025

Real-World Data Presented at TCT 2025 Demonstrates the EggNest™ Complete…

Teamwide protection was also demonstrated: nurses and technologists recorded average exposures of just 0.03 mRem per case, further confirming the EggNest System's ability to safeguard the entire room. Teamwide protection was also demonstrated: nurses and technologists recorded average exposures of just 0.03 mRem per case, further confirming the EggNest System's ability to safeguard the entire room. "Having a radiation protection system that consistently protects my entire team as well as…
PR Newswire
26/10/2025

mediCAD® 8 Revolutionizes Orthopedic and Trauma Planning with Intelligent AI…

At the heart of the new release lies mediCAD AI, a framework that uses advanced algorithms to automatically recognize anatomical landmarks and interpret medical images with remarkable precision. The system detects key reference points across the hip, knee, and lower limb, supporting surgeons with data-driven accuracy from the first step of the planning process. Comparative studies show that landmark detection in mediCAD® 8 achieves an average deviation of less than two millimeters, ensuring...
Nasdaq GlobeNewswire
26/10/2025

138th Canton Fair Showcases Resilience of China's Craft Ceramics and Glassware…

In the Art Ceramics section, another veteran exhibitor is advancing intelligent manufacturing to future-proof its production. The company has been adopting technologies such as 3D printing and digital glazing robots while refining mid-temperature glaze techniques that lower energy consumption and increase material recyclability. These innovations underscore a thoughtful balance between technological progress and environmental responsibility. In the Art Ceramics section, another veteran...
PR Newswire
26/10/2025

Novartis showcases significant immunology advancements in ACR congress with new…

Late-breaking positive Phase III data from ianalumab NEPTUNUS-1 and NEPTUNUS-2 trials in Sjögren’s disease to be presented Biomarker data informing use of investigational CAR-T cell therapy rapcabtagene autoleucel (YTB323) in systemic lupus erythematosus also to be presentedData underscore Novartis commitment to advance innovative medicines for complex, difficult-to-treat autoimmune diseases with high unmet needNovartis to hold virtual investor event following ACR...
Nasdaq GlobeNewswire
25/10/2025

Renowned Indian Entrepreneur Deepinder Goyal Launches 'Continue Research' with a…

Continue Research was founded two years ago as an independent scientific initiative exploring upstream biological mechanisms — the fundamental leverage points where small interventions could meaningfully transform how humans age and live. The team has been investigating a core hypothesis on human aging that, if validated, could significantly reshape current biological understanding. Continue Research was founded two years ago as an independent scientific initiative exploring upstream...
PR Newswire
25/10/2025

Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for…

With enrollment now complete, the company is preparing to submit its CE Mark application to European regulators later this year. Pending approval, commercial launch of the Cardiovalve TR system in Europe is projected for 2027. With enrollment now complete, the company is preparing to submit itsCE Mark applicationto European regulators later this year. Pending approval,commercial launch of the Cardiovalve TR system inEuropeis projected for 2027. Building on this achievement,...
PR Newswire
25/10/2025

Innocan Pharma to Present at the 2025 ThinkEquity Conference

Innocan's presenters will include Iris Bincovich, CEO, Roni Kamhi, COO and Innocan's distinguished advisory board member Dr. Joseph V. Pergolizzi, Jr., M.D, an expert in internal, perioperative and pain medicine, critical and palliative care, pharmacology, drug development and regulatory affairs. Innocan's presenters will include Iris Bincovich, CEO,Roni Kamhi, COO and Innocan's distinguished advisory board member Dr. Joseph V. Pergolizzi, Jr., M.D, an expert in internal, perioperative and...
PR Newswire
24/10/2025

CARBIOS announces the publication of its Interim report for the first half of…

Clermont-Ferrand (France), October 24, 2025 (08:00 pm CEST). CARBIOS (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastics and textiles, informs its shareholders and the financial community that it has made available its Interim report for the first half of 2025. This 2025 Interim report is available in English and can be downloaded from:The Company's website atwww.carbios.comunder the...
Nasdaq GlobeNewswire
24/10/2025

Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices…

As previously announced, through the acquisition of Advent, NWBio is receiving all of Advent's fixed assets, including extensive cryostorage and other equipment purchased by Advent over the last several years. Intellectual property and other intangibles that Advent had acquired are also included. As previously announced, through the acquisition of Advent, NWBio is receiving all of Advent's fixed assets, including extensive cryostorage and other equipment purchased by Advent over the last several…
PR Newswire
24/10/2025

Fagron’s share buy-back program: Weekly update

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 24 October 2025 – 6PM CET Fagron’s share buy-back program: Weekly update In the period from 20 October 2025 through 24 October 2025, Fagron purchased 45,000 of its owns shares at an average price of €21.0115 per share corresponding to a total amount of €945,517.50. These purchases are part of the share buy-back program of up to 200,000 Fagron shares to fulfill Fagron’s obligations under its long-term incentive scheme,...
Nasdaq GlobeNewswire
24/10/2025

Dental tourism enters the winter season in Turkey; Antlara Dental launches…

Advantages of the winter season: Winter visitors benefit from cheaper airfare and lodging costs as well as a more tranquil treatment experience. In addition, dental offices offer seasonal deals that make procedures even cheaper. Along with the financial benefits, the winter air makes it more comfortable for treatment, and wounds that were difficult to heal after treatment because of high temperatures no longer exist. Meanwhile, dental labs see a decrease in business during...
PR Newswire
24/10/2025
Altri  Comunicati